Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

PDGFR

Items 1-10 of 24

Page
per page
  1. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  2. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  3. JNJ-10198409
    C5737 JNJ-10198409
    Summary: inhibitor of platelet-derived growth factor (PDGF-BB) tyrosine kinase
      ≤10 mg/mL
  4. AG-1295
    C5465 AG-1295
    Summary: potent and selective inhibitor of PDGF receptor kinase
      ≥7.73 mg/mL
  5. AG-370
    C4539 AG-370
    Summary: PDGFR inhibitor
      ≤30 mg/mL
  6. SU 16f
    B7354 SU 16f
    Target: PDGFR
    Summary: PDGFRβ inhibitor
      Soluble in DMSO
  7. DMPQ dihydrochloride
    B6642 DMPQ dihydrochloride
    Summary: PDGFRβ inhibitor
      Soluble in H2O
  8. Sunitinib
    B1045 Sunitinib
    Summary: RTK inhibitor
      insoluble in H2O; ≥19.9 mg/mL
  9. Flumatinib mesylate
    A8691 Flumatinib mesylate
    Summary: PDGRFβ inhibitor
      Soluble in DMSO
  10. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met (WT/mutants) inhibitor
      ≥24.8 mg/mL

Items 1-10 of 24

Page
per page